Amber mutation creates a diagnostic MaeI site in the androgen receptor gene of a family with complete androgen insensitivity. |
| |
Authors: | M Trifiro R L Prior N Sabbaghian L Pinsky M Kaufman E G Nylen D D Belsham C R Greenberg K Wrogemann |
| |
Affiliation: | Lady Davis Institute for Medical Research, McGill University, Montreal, Quebec, Canada. |
| |
Abstract: | We have discovered in the X-linked androgen receptor gene a single nucleotide substitution that is the putative cause of complete androgen insensitivity (resistance) in a family with affected individuals in 2 generations. Earlier studies on the family indicated co-segregation of mutant phenotype and the RFLPs at the loci DXS1 and DXYS1. The mutation is an adenine-to-thymine transversion in exon 8 that changes the sense of codon 882 from lysine to an amber (UAG) translation termination signal. The substitution creates a recognition sequence for the restriction endonuclease MaeI: this permits ready recognition of hemizygotes and heterozygotes after amplification of genomic exon 8 by the polymerase chain reaction. The mutation predicts the synthesis of a truncated receptor that lacks 36 amino acids at the carboxy terminus of its 252-amino acid androgen-binding domain. The cultured genital skin fibroblasts of the one affected patient examined have normal levels of androgen receptor mRNA, but negligible androgen-receptor binding activity. These results accord with a variety of data from spontaneous and artificial mutations indicating that all portions of the steroid binding domain contribute to normal steroid binding by a steroid receptor. |
| |
Keywords: | |
|
|